Company Profile
Updated: 26-OCT-09Avecia Group Ltd.
International Private company
PO Box 42, Hexagon House, Blackley, Manchester, M9 8ZS, United Kingdom
()44 0161 721 1013, 44 0161 721 5202 fax, http://www.avecia.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: The group now operates two main businesses within the Biotechnology segment, Biologics and Oligo Medicines, having disposed of its remaining specialty chemicals business segments during 2005 and 2006.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Merck buys British maker of biotech medicines
AP Worldstream; 12/17/2009; 759 words; ...Merck Sharp & Dohme Ltd., has agreed to acquire Avecia Biologics from its parent...well below $1 billion. Avecia has been making small...for client Dyax Corp. Avecia spokeswoman Bridget Hall...manufacturing facility and a group of potential generic...
Publication No. WO/2009/138714 Published on Nov. 19, Assigned to Avecia Biologics for Purification Process (British Inventor)
US Fed News Service, Including US State News; 11/20/2009; 432 words; ...patent has been assigned to Avecia Biologics Ltd., Manchester, Great...optionally via a spacer group; A and B are each independently...phenyl or -Y-naphthyl groups substituted with one or...represents H or a C1-4 alkyl group." The invention carries...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1248 words; o Avecia Biotechnology Inc...contract awarded to Avecia in September 2003 for...the Therapeutic Antibody Group of Medical Research Council...Hiroshi, Kenso Kogyo Co. Ltd., Kyokuto Securities Co. Ltd., Medikit Co. Ltd...
"The global vaccines market, worth $25bn in 2009, is expected to sustain double-digit growth over the next 15 years, rising to over $100bn by 2024." Says Visiongain Conference.
M2 Presswire; 4/15/2009; 1201 words; ...2009 M2 COMMUNICATIONS LTD RDATE:15042009 San Francisco...dominated by a select group of key players, technology...Science and Technology, Avecia Biologics * Daniel Galbraith...Venture Capital Visiongain ltd.Visit at: http...M2 Communications Ltd disclaims all liability...
January 2009 - Rahu Appoints David Greensmith to Non Executive Director.
PR Newswire Europe; 2/2/2009; 674 words; ...Director Fujifilm, Chief Operating Officer of Avecia, and as one of the three directors leading...Associates in Tropical Health, Chairman of MatOx Ltd and Non Exec Director of the Warwick International Group Ltd. Commenting on the appointment, Rahu CEO...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning